After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Verve Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Verve Therapeutics Inc is $513.24M. A total of 0.98 million shares were traded on the day, compared to an average of 1.44M shares.
In the most recent transaction, Dorval Allison sold 555 shares of VERV for 5.64 per share on Dec 02 ’24. After the transaction, the Chief Financial Officer now owns 5,380 company shares. In a previous transaction on May 14 ’24, Ashe Andrew D. bought 76,000 shares at 6.26 per share. VERV shares that the insider owns now total 342,509.
Among the insiders who sold shares, Nickerson Joan disposed of 1,514 shares on Apr 02 ’24 at a per-share price of $8.24. This resulted in the Chief Administrative Officer holding 8,659 shares of VERV after the transaction.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VERV has a high of $13.63 and a low of $4.30.
As of this writing, VERV has an earnings estimate of -$0.65 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.51 per share and a lower estimate of -$0.77.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VERV’s latest balance sheet shows that the firm has $360.44M in Cash & Short Term Investments as of fiscal 2021. There were $1.96M in debt and $22.02M in liabilities at the time. Its Book Value Per Share was $5.56, while its Total Shareholder’s Equity was $357.35M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERV is Buy with a score of 4.50.
